Government targets New Year quiters
January 7, 2010smoking cessation
The government has launched its latest weapon in the battle to wrest people away from their nicotine addiction. The NHS …
Pharma welcome for Senate healthcare reform vote
January 6, 2010Sales and Marketing Obama, Senate, US healthcare
Pharma manufacturers have welcomed the passing of the US Senate’s healthcare reform bill on Christmas Eve. Ken Johnson, senior vice …
DMV-Fonterra plans another shake-up for pharma lactose
January 6, 2010Manufacturing and Production DMV-Fonterra Excipients, FrieslandCampina Domo, lactose
DMV-Fonterra Excipients has agreed to buy the product range of FrieslandCampina Domo for 52.5 million euros in a deal that …
Alcon directors protest Novartis takeover bid
January 6, 2010Research and Development, Sales and Marketing Alcon, Novartis
An independent committee of directors of Alcon has expressed its disappointment with the recent takeover bid from Novartis, saying the …
Hospira helps Genzyme tackle manufacturing problems
January 6, 2010Manufacturing and Production Cerezyme, Fabrazyme, Genzyme, Hospira
Genzyme has taken the decision to move the fill and finish stages of its manufacturing process to Hospira in order …
NICE chief executive knighted in New Year’s honours
January 6, 2010Andrew Dillon, NHS, NICE, UK, appointment
Andrew Dillon, chief executive of the National Institute for Health and Clinical Excellence (NICE), has been knighted in the 2010 …
Dr Julie Gerberding appointed to head up Merck Vaccines
January 6, 2010Research and Development, Sales and Marketing Merck, appoinment, research and development, sales and marketing, vaccines
Merck & Co has put a US public health and infectious diseases expert in charge of its $5 billion global …
Steve Lowery joins Synovate
January 6, 2010Sales and Marketing appointment, sales and marketing, synovate
Marketing intelligence agency Synovate has appointed Steve Lowery group head, custom healthcare, in the UK. Lowery joins Synovate from Kantar …
GSK’s Andrew Witty appointed president of EFPIA
January 5, 2010Research and Development, Sales and Marketing Andrew Witty, EFPIA, GSK, appointment, research and development, sales and marketing
GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …
Novartis to acquire majority stake in Alcon
January 5, 2010Sales and Marketing Alcon, Novartis, eye care
Novartis plans to gain a majority hold of global eye care leader Alcon, significantly boosting its presence in the sector. …
Sanofi bags consumer healthcare specialist Chattem
January 5, 2010Chattem, OTC, Sanofi
Sanofi-Aventis looks set to become much bigger in over-the-counter pharmaceuticals with a $1.9 billion agreement to buy US company Chattem. …
Strong growth predicted for pharma contract services
January 5, 2010Manufacturing and Production, Research and Development contract research, industry, manufacturing and production
The market for contract services in the pharmaceutical sector has been pegged back since the end of 2008, but looks …
Lilly extends remit for finance chief Derica Rice
January 5, 2010Sales and Marketing appointment, lilly, sales and marketing
Lilly’s senior vice president and chief financial officer Derica Rice has taken on an expanded role. He becomes executive vice …
Roche plans striking new Basel offices
January 4, 2010Manufacturing and Production, Research and Development, Sales and Marketing Basel, Roche, construction
Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …
Serge Weinberg joins board at Sanofi-Aventis
January 4, 2010Research and Development, Sales and Marketing Sanofi-Aventis, appointment, research and development, sales and marketing
Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …
Medea wins European sedative account
January 4, 2010Medical Communications Medea, orion, sedative
Medical communications agency Medea Communications has landed a brief to prepare the ground for a new sedative from Finnish company …
Cancer Research UK and Merck KGaA to co-develop leukaemia candidate
January 4, 2010Research and Development Merck Serono, leukaemia, oncology
Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …
New approaches in lung cancer
January 1, 2010Sales and Marketing lung cancer
Lung cancer is the most common cancer in the world, with 1.3 million new cases diagnosed every year. The vast …
Celgene
January 1, 2010Research and Development, Sales and Marketing Abraxane, Celgene, Revlimid, Thalidomide
Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …
Patient involvement must improve, says European regulator
December 31, 2009Sales and Marketing EMEA, patients
The European Medicines Agency (EMEA) has admitted that the level of patient involvement in its activities is unsatisfactory.As a result …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
